130 related articles for article (PubMed ID: 30361237)
1. Evidence for the Validity of Pyridoxic Acid (PDA) as a Plasma-Based Endogenous Probe for OAT1 and OAT3 Function in Healthy Subjects.
Shen H; Holenarsipur VK; Mariappan TT; Drexler DM; Cantone JL; Rajanna P; Singh Gautam S; Zhang Y; Gan J; Shipkova PA; Marathe P; Humphreys WG
J Pharmacol Exp Ther; 2019 Jan; 368(1):136-145. PubMed ID: 30361237
[TBL] [Abstract][Full Text] [Related]
2. Discovery and Validation of Pyridoxic Acid and Homovanillic Acid as Novel Endogenous Plasma Biomarkers of Organic Anion Transporter (OAT) 1 and OAT3 in Cynomolgus Monkeys.
Shen H; Nelson DM; Oliveira RV; Zhang Y; Mcnaney CA; Gu X; Chen W; Su C; Reily MD; Shipkova PA; Gan J; Lai Y; Marathe P; Humphreys WG
Drug Metab Dispos; 2018 Feb; 46(2):178-188. PubMed ID: 29162614
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Elimination Pathways and the Feasibility of Endogenous Metabolites as Biomarkers of Organic Anion Transporter 1/3 Inhibition in Cynomolgus Monkeys.
Liu R; Hao J; Zhao X; Lai Y
Drug Metab Dispos; 2023 Jul; 51(7):844-850. PubMed ID: 37059471
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic modeling and simulation to support qualification of pyridoxic acid as endogenous biomarker of OAT1/3 renal transporters.
Ahmad A; Ogungbenro K; Kunze A; Jacobs F; Snoeys J; Rostami-Hodjegan A; Galetin A
CPT Pharmacometrics Syst Pharmacol; 2021 May; 10(5):467-477. PubMed ID: 33704919
[TBL] [Abstract][Full Text] [Related]
5. Detection of Weak Organic Anion-Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans.
Zhang Y; Holenarsipur VK; Kandoussi H; Zeng J; Mariappan TT; Sinz M; Shen H
Drug Metab Dispos; 2020 Oct; 48(10):841-848. PubMed ID: 32723847
[TBL] [Abstract][Full Text] [Related]
6. Clinical Investigation on Endogenous Biomarkers to Predict Strong OAT-Mediated Drug-Drug Interactions.
Willemin ME; Van Der Made TK; Pijpers I; Dillen L; Kunze A; Jonkers S; Steemans K; Tuytelaars A; Jacobs F; Monshouwer M; Scotcher D; Rostami-Hodjegan A; Galetin A; Snoeys J
Clin Pharmacokinet; 2021 Sep; 60(9):1187-1199. PubMed ID: 33840062
[TBL] [Abstract][Full Text] [Related]
7. Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 Inhibition.
Tang J; Shen H; Zhao X; Holenarsipur VK; Mariappan TT; Zhang Y; Panfen E; Zheng J; Humphreys WG; Lai Y
Drug Metab Dispos; 2021 Dec; 49(12):1063-1069. PubMed ID: 34599018
[TBL] [Abstract][Full Text] [Related]
8. Development of 4-Pyridoxic Acid PBPK Model to Support Biomarker-Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease.
Tan SPF; Willemin ME; Snoeys J; Shen H; Rostami-Hodjegan A; Scotcher D; Galetin A
Clin Pharmacol Ther; 2023 Dec; 114(6):1243-1253. PubMed ID: 37620246
[TBL] [Abstract][Full Text] [Related]
9. Effect of probenecid on blood levels and renal elimination of furosemide and endogenous compounds in rats: Discovery of putative organic anion transporter biomarkers.
Thakur A; Saradhi Mettu V; Singh DK; Prasad B
Biochem Pharmacol; 2023 Dec; 218():115867. PubMed ID: 37866801
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
[TBL] [Abstract][Full Text] [Related]
11. Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
Tsuruya Y; Kato K; Sano Y; Imamura Y; Maeda K; Kumagai Y; Sugiyama Y; Kusuhara H
Drug Metab Dispos; 2016 Dec; 44(12):1925-1933. PubMed ID: 27638508
[TBL] [Abstract][Full Text] [Related]
12. A novel hydrophilic interaction chromatography assay characterization of 4-pyridoxic acid, an emergent renal organic anion transporter 1/3 transporter biomarker.
Towner J; Rago B; Rodrigues D; Vourvahis M; Holliman C
Bioanalysis; 2021 Sep; 13(18):1391-1400. PubMed ID: 34551579
[No Abstract] [Full Text] [Related]
13. 6β-Hydroxycortisol is an endogenous probe for evaluation of drug-drug interactions involving a multispecific renal organic anion transporter, OAT3/SLC22A8, in healthy subjects.
Imamura Y; Tsuruya Y; Damme K; Heer D; Kumagai Y; Maeda K; Murayama N; Okudaira N; Kurihara A; Izumi T; Sugiyama Y; Kusuhara H
Drug Metab Dispos; 2014 Apr; 42(4):685-94. PubMed ID: 24487120
[TBL] [Abstract][Full Text] [Related]
14. Renal expression and function of oat1 and oat3 in rats with vascular calcification.
Bulacio R; Hazelhoff MH; Torres AM
Pharmacology; 2012; 90(1-2):66-77. PubMed ID: 22759781
[TBL] [Abstract][Full Text] [Related]
15. Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development.
Takahara N; Saga T; Inubushi M; Kusuhara H; Seki C; Ito S; Oyama N; Yokoyama O; Sugiyama Y; Fujibayashi Y
Nucl Med Biol; 2013 Jul; 40(5):643-50. PubMed ID: 23618840
[TBL] [Abstract][Full Text] [Related]
16. Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.
Kim YC; Kim IB; Noh CK; Quach HP; Yoon IS; Chow ECY; Kim M; Jin HE; Cho KH; Chung SJ; Pang KS; Maeng HJ
J Pharm Sci; 2014 Nov; 103(11):3793-3805. PubMed ID: 25266751
[TBL] [Abstract][Full Text] [Related]
17. Non randomized study on the potential of nitisinone to inhibit cytochrome P450 2C9, 2D6, 2E1 and the organic anion transporters OAT1 and OAT3 in healthy volunteers.
Huledal G; Olsson B; Önnestam K; Dalén P; Lindqvist D; Kruse M; Bröijersén A
Eur J Clin Pharmacol; 2019 Mar; 75(3):313-320. PubMed ID: 30443705
[TBL] [Abstract][Full Text] [Related]
18. Identification and Quantitative Assessment of Uremic Solutes as Inhibitors of Renal Organic Anion Transporters, OAT1 and OAT3.
Hsueh CH; Yoshida K; Zhao P; Meyer TW; Zhang L; Huang SM; Giacomini KM
Mol Pharm; 2016 Sep; 13(9):3130-40. PubMed ID: 27467266
[TBL] [Abstract][Full Text] [Related]
19. Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis.
Chen J; Terada T; Ogasawara K; Katsura T; Inui K
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F247-52. PubMed ID: 18480179
[TBL] [Abstract][Full Text] [Related]
20. Interaction of human organic anion transporters with various cephalosporin antibiotics.
Takeda M; Babu E; Narikawa S; Endou H
Eur J Pharmacol; 2002 Mar; 438(3):137-42. PubMed ID: 11909604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
